https://jupiterendo.com/jupiter-endovascular-exits-stealth-with-21m-in-new-financing-to-fund-pivotal-trial-for-pulmonary-embolism/ 2024-08-15T14:00:02+00:00 https://jupiterendo.com/jupiter-endovascular-receives-fda-approval-for-u-s-pivotal-study-of-vertex-pulmonary-embolectomy-system-using-endoportal-control/ 2024-08-29T21:40:10+00:00 https://jupiterendo.com/jupiter-endovascular-announces-first-patients-successfully-treated-in-first-clinical-study-of-vertex-pulmonary-embolectomy-system-using-endoportal-control/ 2024-09-19T12:01:11+00:00 https://jupiterendo.com/jupiter-endovascular-announces-first-u-s-patient-treated-with-vertex-pulmonary-embolectomy-system-using-endoportal-control/ 2024-10-25T12:00:00+00:00 https://jupiterendo.com/wp-content/uploads/2024/08/jupiter-social.jpg https://jupiterendo.com/jupiter-endovascular-appoints-fred-ong-as-chief-financial-officer/ 2025-02-26T13:00:00+00:00 https://jupiterendo.com/wp-content/uploads/2024/08/jupiter-social.jpg https://jupiterendo.com/jupiter-endovascular-closes-oversubscribed-series-b-financing-surpassing-40-million-target/ 2025-10-07T12:11:44+00:00 https://jupiterendo.com/wp-content/uploads/2024/08/jupiter-social.jpg https://jupiterendo.com/jupiter-endovascular-announces-positive-results-from-spirare-i-first-in-human-study-presented-at-tct-2025/ 2025-10-26T19:30:00+00:00 https://jupiterendo.com/wp-content/uploads/2024/08/jupiter-social.jpg https://jupiterendo.com/jupiter-endovascular-announces-completion-of-enrollment-in-spirare-ii-pivotal-trial/ 2026-02-04T13:00:04+00:00 https://jupiterendo.com/jupiter-endovascular-announces-positive-results-from-spirare-ii-pivotal-trial-at-europcr2026/ 2026-05-20T23:54:52+00:00 https://jupiterendo.com/jupiter-endovascular-appoints-catalin-toma-mdas-chief-medical-officer/ 2026-08-13T13:00:11+00:00